|
April 2004
In March 2002 I was in a cafe across the road from my
office in Jerusalem when a suicide bomber exploded next to
me. Amazingly I survived (although eleven others did not),
with permanent damage only to my hearing. I was later
diagnosed with PTSD. The presentation of PTSD can be
complex with many possible expressions, and my symptoms indicated the "arousal" type.
In my personal search to fulfill new psychological
needs, I began to use MDMA at parties. MDMA use in this
very social and very stimulatory context enabled me to
reach profound and satisfying levels of emotional experience.
At the same time I was getting psychological support
from a National Insurance-sponsored psychologist
(interestingly, she felt that my MDMA self-medication was a
way of attempting to gain control of the original traumatic
incident).
However, beyond these immediate effects, it was the
effect that lasted up to 48 hours following MDMA ingestion
that intrigued me. A cognitive exercise that I did
under the guidance of my psychologist, involving logging
all my PTSD occurrences, revealed consistently zero PTSD
manifestations for the two days following MDMA use. This
discovery is what prompted me to survey the literature
on MDMA in PTSD therapy, find MAPS, and prepare this
report at Dr. Doblin's request, in the hope it will help with
his effort to further study in this area. I must point out that
I have no experience with MDMA as part of psychotherapy,
nor do I have any reason to think it would be especially
beneficial in that context.
I am not happy using MDMA because, as production
and distribution of the material is both illegal and
unsupervised, I don't know exactly what composition I'm
ingesting, the effects vary according to the batch, and there
is also a negative social stigma.
I should also point out that I tried SSRIs on two separate occasions
(paroxetine and sertraline) but had to abort
because of side effects on my problematic gastrointestinal
system.
I would be happy to be able to use MDMA in a legal and
supervised context, and I therefore support Dr. Doblin in
his project.
An update in May 2005:
A year ago I wrote a report for MAPS on my personal
experience with MDMA. I reported that I was using
MDMA on a weekly basis in order to alleviate symptoms
of PTSD. Typically I would have an emotionally fulfilling
experience at the time of ingestion, followed by two days
free of PTSD symptoms. This would help me get through
the week while functioning normally and fulfilling my
obligations.
As an update, I can report a few interesting points from
my experience over the past year:
- Being treated all the while with conventional psychotherapy
sponsored by Israeli National Insurance,
I was prescribed antidepressants. As in the past, these
were eventually discontinued due to their numerous
and various side effects, from tremour and dry mouth
to gastrointestinal and sexual dysfunction. MDMA,
however, had no apparent side effects.
- I have not used MDMA for several weeks now in
order to test dependency. I can report that I have no
sense of desire for the substance and no withdrawal
symptoms, so apparently no dependence.
- Overall, I feel today more connected to life. I attribute
this to my two years of experience with MDMA
and the assistance it afforded me in reconnecting to
people, music, love, et cetera.
- MDMA, however, has not been a panacea, and I am
still struggling with PTSD.
I wish to emphasize the obvious, that my report is not
scientific by any means, and no operative conclusions
should be reached from it. And this is precisely why I support
MAPS. Proper long-term clinical research needs to be
done so we can ascertain the usefulness of MDMA.
Overall, I feel today more connected to life.
I attribute this to my two years of experience
with MDMA and the assistance it afforded me in
reconnecting to people, music, love, et cetera.
|